Infinity Pharmaceuticals Investor Relations Material
Latest events
Investor Update
Infinity Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Infinity Pharmaceuticals Inc
Access all reports
Infinity Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative therapies for cancer. The company's research primarily targets the immune system to enhance the body's ability to fight cancer. Infinity’s lead drug candidates aim to treat various types of solid tumors by modulating key immune pathways and working in combination with other therapies to improve patient outcomes. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
INFI
Country
🇺🇸 United States